Log in to save to my catalogue

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8524784

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

About this item

Full title

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2021-06, Vol.384 (23), p.2259-2261

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

A total of 33 participants who received both doses of the Moderna mRNA-1273 vaccine against SARS-CoV-2 had blood drawn over a period of 6 months after vaccination. SARS-CoV-2 neutralizing activity was maintained in all the patients through the entire period of follow-up. A half-life of 202 days was determined for the live-virus neutralization activ...

Alternative Titles

Full title

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8524784

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8524784

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMc2103916

How to access this item